Table 1. Distribution of diversin status in breast cancer according to clinicopathological characteristics.
| Characteristics | Number of patients | diversin negative | diversin positive | P |
| Age | ||||
| <60 | 124 | 79 | 45 | 0.9263 |
| ≥60 | 35 | 22 | 13 | |
| TNM stage | ||||
| I | 62 | 48 | 14 | 0.0036 |
| IIIII | 97 | 53 | 44 | |
| Tumor size | ||||
| <2 cm | 56 | 39 | 17 | 0.2371 |
| ≥2 cm | 103 | 62 | 41 | |
| Lymph node metastasis | ||||
| Absent | 82 | 61 | 21 | 0.0033 |
| Present | 77 | 40 | 37 | |
| Estrogen receptor | ||||
| Absent | 59 | 28 | 31 | 0.0012 |
| Present | 100 | 73 | 27 | |
| Progesterone receptor | ||||
| Absent | 77 | 44 | 33 | 0.1054 |
| Present | 82 | 57 | 25 | |
| ErbB-2 | ||||
| Absent | 118 | 73 | 45 | 0.4613 |
| Present | 41 | 28 | 13 | |
| Triple-negative | ||||
| Absent | 121 | 85 | 36 | 0.0017 |
| Present | 38 | 16 | 22 |